A close up of a magnifying glass rests on top of a bar graph that shows declining sales or performance over a quarterly basis. The image is photographed using a very shallow depth of field.

Skinny tan maker Innovaderma PLC (LON:IDP) doubled profits and predicted more to come as Boots has added more ranges to its shelves.

Digitalbox PLC (LON:DBOX) expects trading for the second half of the year to be better than the first and said it will continue to look for acquisitions akin to The Daily Mash, which it purchased in March.

UK Oil & Gas PLC (LON:UKOG) has told investors that the drill rig has now arrived on site ahead of the upcoming horizontal well at the Horse Hill project, near Gatwick.

Investors in Alba Mineral Resources plc (LON:ALBA) are now counting down to the start of new drilling at the Horse Hill oil project, where a drill rig has now arrived.

Polarean Imaging PLC (LON:POLX) expects top-line data for its two clinical trials to be available by the year-end.

Bluebird Merchant Ventures Ltd (LON:BMV), the Korean-focused gold development group, has received formal communication from the South Korean government confirming that the application for a ‘Permit to Develop’ the Gubong mine is to be granted.

Kromek Group PLC (LON:KMK) has won two contract extensions for its D3S nuclear detection platform worth a combined £1.6mln in the current year.

Rosslyn Data Technologies PLC (LON:RDT) has snapped up bulk supply chain data specialist Langdon Systems from the administrators for less than £50,000 cash.

Alliance Pharma PLC (LON:APH) said it was on track to hit full-year expectations as it delivered a solid first-half performance, underpinned by its “star” international brands.

DP Poland PLC (LON:DPP) has reported rising system sales in the first half of the year as it looked to expand its sub-franchise estate over the rest of the year.

S&U PLC (LON:SUS) has pulled in industry heavyweight Graham Wheeler to run its car lending arm, Advantage. He will replace Guy Thompson, who wants to retire next year having helped set up the Advantage business and run it for twenty years.

Greatland Gold PLC (LON:GGP) has confirmed the presence of broad widths of gold mineralisation at its Firetower project in Tasmania, following a diamond drilling programme.

Kavango Resources PLC (LON:KAV) has selected targets for drilling at its Kalahari Suture Zone project in Botswana.

Aminex PLC (LON:AEX) says it has seen positive movements in Tanzania with the government actively resolving several long-standing issues with other operators in the country that bode well for its Ruvuma project.

Solo Oil PLC (LON:SOLO), which has a 25% stake in Ruvuma, said Aminex’s release was “clearly a positive update for Solo” and its partners on the project and “moves us a step closer to realising the core value of our material interest in this high quality asset”.

Plexus Holdings Plc (LON:POS) has installed the first jack-up exploration wellhead in its inaugural POS-GRIP rental contract with Gazprom.

Silence Therapeutics PLC (LON:SLN) has hit the first milestone in a deal with a US drugs company in just two months, triggering a US$2mln research payment.

Primary Health Properties PLC (LON:PHP) squeezed £100mln from institutional investors as it spies “very attractive” opportunities to develop new healthcare premises in Ireland and the UK.

Hurricane Energy Plc (LON:HUR) has announced the spudding of the Warwick West exploration well in the Greater Warwick portion of its Rona Ridge project.

Midatech Pharma PLC (LON:MTPH; NASDAQ:MTP) has filed what’s called a shelf registration with the US Securities & Exchange Commission that would allow it to raise up to US$50mln.

Europa Oil & Gas Plc (LON:EOG) has told investors it is seeking clarification of the situation through the offices of the Irish Offshore Operators’ Association following a speech by Leo Varadkar to the United Nations climate summit on Monday.

Summit Therapeutics plc (LON:SUMM, NASDAQ:SMMT) will present encouraging new data analyses from the Phase 2 clinical trial of ridinilazole in patients with C. difficile infection at ID Week 2019, taking place in early October in Washington, DC. The data further shows ridinilazole’s superior clinical outcomes over the current standard of care.